The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,789.50
Bid: 1,789.00
Ask: 1,789.50
Change: 11.50 (0.65%)
Spread: 0.50 (0.028%)
Open: 1,780.00
High: 1,791.00
Low: 1,766.50
Prev. Close: 1,778.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LIVE MARKETS-Messy markets! What to buy?

Wed, 21st Oct 2020 12:28

* European stocks fall for second straight session

* Centamin shares down 20% after production update

* Construction sector dips 1.5%
Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You
can share your thoughts with us at markets.research@thomsonreuters.com

MESSY MARKETS! WHAT TO BUY? (1128 GMT)

A vaccine approval, shorter/less-strict social restrictions, coupled with a strong economic
growth, a moderate rise in inflation rates and a weak dollar are possibilities to look forward
to in 2021.

And, if this materializes, Credit Suisse analysts have some ideas:

- European renewables, as wind capacity is expected to rise by 15-fold in the next 20 years
and the carbon price to be at $100 ton by 2030; besides grids deserve un upgrade, including RWE
, EDP,, National Grid

- Mining stocks, thanks to Chinese infrastructure investments seen remaining strong. CS
analysts highlight Anglo American.

- Construction materials, as U.S. housing is set to grow 20% on very low bond yields and
governments are focused on infrastructure. They “like stocks exposed to insulation.”

- China tech, as P/E relatives are at 15-year lows while earnings revisions remain very
strong and there are “all the ingredients of a bubble that has yet to really start.”

- Defence, as spending will grow in a tri-polar world and telecom equipment with 5G a
superfast broadband seen as a necessity. CS says U.S. valuations in defence sector at 20-year
lows, with BAE “looking abnormally cheap.”

(Stefano Rebaudo)

*****

WHEN WILL UK DIVIDENDS BOUNCE BACK TO PRE-PANDEMIC LEVELS? (0900 GMT)

It's anyone's guess!

Link Group says the best case scenario is a recovery to 2012-13 levels in 2021.

UK dividends have recovered a tad from the depths of last quarter but they still had the
lowest third quarter in ten years, leaving investors eager to find out how much they will wait
to see payouts levels bouncing back.

Underlying dividends, which exclude special payments, fell 45.1% to £17.7bn in Q3, according
to Link Group.

"Though by any normal standards a fall of this magnitude is terrible for investors, it is
significantly better than the 57.2% drop in the second quarter," it says.

Link Group adds that investors will likely only see dividends recovering by March 2021 and
it pencils in a best-case increase of 15% and a worst case of 6% for next year.

"The fourth quarter this year and the first quarter next are set for further sharp declines,
but from April onwards, the anniversary of the lockdown, the comparisons will start to look more
favourable and we expect to see a bounce-back begin".

(Joice Alves)

******

EUROPEAN STOCKS HEAD LOWER (0800 GMT)

European stocks dipped for the second straight day dragged down by construction, healthcare
and oil outweighing a decent batch of better-than-expected Q3 results.

The STOXX 600 is down 0.6%, with the construction sector leading the losses.

In terms of single stocks, Shares in Ericsson are up 7%, after quarterly core
earnings beat market estimates and the company says it is "more confident" in meeting its 2020
targets.

Mining company Centamin's shares fell to the bottom of the pan European index, down
18% after the company’s production update.

Shares in Iberdrola are down 0.6%, after the company issued results and announced
its U.S. unit Avangrid agreed to buy U.S. utility PNM Resources for around $4.3
billion.

(Stefano Rebaudo and Joice Alves)

*****

ON THE RADAR: IBERDROLA UNIT MERGER, AKZO NOBEL, ERICSSON (0639 GMT)

European stocks are poised to open higher, with sentiment boosted by hopes for a U.S. rescue
package and better-than-feared earnings results.

While concerns about the pandemic in Europe continue to weigh, we have a decent batch of
corporate news to cheer up investors, starting with a multi-billion cross border merger in the
renewable energy sector. Avangrid, the U.S. unit of Iberdrola, has agreed to
buy U.S. utility PNM Resources for around $4.3 billion. The merged company would have
assets worth $40 billion and generate core earnings of around $2.5 billion and net profit of
$850 million.

Akzo Nobel reports a better-than-expected 18% increase in third-quarter core
profit to 353 million euros.

Nestle stocks are up 2.7% in premarket trade after the company beats Q3 sales
expectations and raises its guidance for 2020.

Ericsson quarterly core earnings beat market estimates, helped by higher margins
and China's 5G rollout, and is "more confident" in meeting its 2020 targets.

Good news also on the vaccine front as AstraZeneca Plc's trial in the United States
is expected to resume as early as this week after the U.S. Food and Drug Administration
completed its review of a serious illness in a study participant.

But we still see pressure on the financial sector. Shares in GAM Holding are down
2.2% in premarket trade after results., while Handelsbanken reports
lower-than-expected quarterly net earnings due to restructuring costs.

Vinci expects earnings to continue falling in the second half of the year, as
weakness at its pandemic-ravaged airports business outweighs signs of a recovery in construction
and motorway traffic.

GlaxoSmithKline would move its experimental vaccine against the respiratory
syncytial virus (RSV), a cause of pneumonia in toddlers and the elderly, into the final stage of
testing, encouraged by mid-stage trial results.

Shares in Bilfinger are up 7.2% after press reports on possible takeover of the
company.

(Stefano Rebaudo)

*****

EUROPE CAUTIOUSLY IN THE BLACK (0528 GMT)

European stock futures are in the black along with their U.S. peers as hopes of a quick
approval of a U.S. stimulus package are propping up risk sentiment.

But investors continue to be cautious as coronavirus trajectories as well as possible new
restrictive measures are now seen as the single biggest near-term risk to the economic recovery.

Italy, Spain and Britain are considering new restrictions, including curfew in hard-hit
regions, to limit the spread of the pandemic. The latest curbs in Ireland will see GDP fall by
3.5% this year, Finance Minister Paschal Donohoe said.

(Stefano Rebaudo)

*****

More News
17 May 2024 08:39

GSK raises $1.5 bln from sale of remaining Haleon stake

May 17 (Reuters) - British drugmaker GSK has raised 1.25 billion pounds ($1.52 billion) from a sale of its remaining stake in consumer healthcare company Haleon to institutional investors.

Read more
17 May 2024 07:42

LONDON BRIEFING: Land Securities ups dividend; GSK sells Haleon stake

(Alliance News) - Stocks in London are called to open lower, as investors wait for an inflation reading from the eurozone later this morning.

Read more
17 May 2024 07:29

GSK raises £1.25bn from sale of remaining Haleon stake

(Sharecast News) - GSK said on Friday that it has sold its remaining 4.2% stake in consumer health business Haleon, which it spun off in July 2022.

Read more
16 May 2024 17:33

FTSE 100 ends lower on disappointing corporate updates, BT Group soars

BT Group up after CEO aims for more than double free cash flow

*

Read more
16 May 2024 17:13

TOP NEWS: GSK to sell remaining holding in spin-off Haleon

(Alliance News) - GSK PLC on Thursday said it intends to sell its remaining stake in Haleon PLC, the consumer healthcare firm it spun out almost two years ago.

Read more
16 May 2024 17:02

GSK to sell entire 4.2% remaining stake in Haleon

(Sharecast News) - GSK said on Thursday that it plans to sell its entire remaining 4.2% stake in Haleon.

Read more
16 May 2024 16:54

LONDON MARKET CLOSE: Europe struggles but record highs in New York

(Alliance News) - Large-cap European equities closed lower on Thursday, underperforming New York counterparts, which continued to push higher following Wednesday's softer US inflation data.

Read more
16 May 2024 16:53

London close: Stocks mixed as ex-divs drag on FTSE

(Sharecast News) - London stocks ended mixed on Thursday, following a flurry of corporate news and a focus on US unemployment figures.

Read more
14 May 2024 10:11

LONDON BROKER RATINGS: DB and Berenberg raise Diploma price target

(Alliance News) - the following London-listed shares received analyst recommendations Monday and Tuesday morning:

Read more
13 May 2024 09:41

LONDON BROKER RATINGS: BAE Systems and Mondi cut to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:

Read more
12 May 2024 14:50

French presidency: Amazon to announce new 1.2 bln euros investment in France

PARIS, May 12 (Reuters) - U.S. internet giant Amazon will announce a new 1.2 billion euros ($1.3 billion) investment in France, the French presidency said on Sunday ahead of the start of the country's annual "Choose France" event.

Read more
9 May 2024 15:51

UK dividends calendar - next 7 days

Friday 10 May 
AIB Group PLCdividend payment date
Alpha Group International PLCdividend payment date
Antofagasta PLCdividend payment date
Hammerson PLCdividend payment date
Hunting PLCdividend payment date
International Personal Finance PLCdividend payment date
Invesco Select Trust Global Equity Income PLCdividend payment date
Invesco Select Trust UK Equity PLCdividend payment date
Johnson Service Group PLCdividend payment date
Kerry Group PLCdividend payment date
Moneysupermarket.com Group PLCdividend payment date
Schroder Asian Total Return Inv Co PLCdividend payment date
Schroder European Real Estate Investments Trust PLCdividend payment date
Schroder Oriental Income Fund Ltddividend payment date
Serco Group PLCdividend payment date
Smurfit Kappa Group PLCdividend payment date
Somero Enterprises Incspecial dividend payment date
Taylor Wimpey PLCdividend payment date
Tufton Oceanic Assets Ltddividend payment date
VPC Specialty Lending Investments PLCdividend payment date
Monday 13 May 
Games Workshop Group PLCdividend payment date
Life Science REIT PLCdividend payment date
Seed Innovations Ltdspecial dividend payment date
Smiths Group PLCdividend payment date
VinaCapital Vietnam Opportunity Fund Ltddividend payment date
Tuesday 14 May 
BlackRock World Mining Trust PLCdividend payment date
Fidelity European Trust PLCdividend payment date
InterContinental Hotels Group PLCdividend payment date
Mondi PLCdividend payment date
OSB Group PLCdividend payment date
Rathbones Group PLCdividend payment date
Uniphar PLCdividend payment date
Wednesday 15 May 
Capital Ltddividend payment date
Grit Real Estate Income Group Ltddividend payment date
Jardine Matheson Holdings Ltddividend payment date
Just Group PLCdividend payment date
Rentokil Initial PLCdividend payment date
Thursday 16 May 
abrdn Property Income Trust Ltdex-dividend payment date
Alternative Income REIT PLCex-dividend payment date
Aquila European Renewables PLCex-dividend payment date
Balfour Beatty PLCex-dividend payment date
BlackRock Latin American Investment Trust PLCdividend payment date
BP PLCex-dividend payment date
Bunzl PLCex-dividend payment date
Churchill China PLCex-dividend payment date
EJF Investments Ltdex-dividend payment date
Essentra PLCex-dividend payment date
Fevertree Drinks PLCex-dividend payment date
FRP Advisory Group PLCex-dividend payment date
Greencoat UK Wind PLCex-dividend payment date
GSK PLCex-dividend payment date
Haleon PLCdividend payment date
Henderson Opportunities Trust PLCex-dividend payment date
Income & Growth VCT PLCex-dividend payment date
Irish Continental Group PLCex-dividend payment date
James Halstead PLCex-dividend payment date
Jarvis Securities PLCex-dividend payment date
Kingfisher PLCex-dividend payment date
M Winkworth PLCdividend payment date
Majedie Investments PLCex-dividend payment date
Manx Financial Group PLCex-dividend payment date
Mercantile Investment Trust PLCdividend payment date
Morgan Sindall Group PLCdividend payment date
Murray Income Trust PLCex-dividend payment date
Ocean Wilsons Holdings Ltdex-dividend payment date
Octopus Renewables Infrastructure Trust PLCex-dividend payment date
PageGroup PLCex-dividend payment date
Pershing Square Holdings Ltdex-dividend payment date
Princess Private Equity Holding Ltdex-dividend payment date
Property Franchise Group PLCex-dividend payment date
Prudential PLCdividend payment date
RHI Magnesita NVex-dividend payment date
Shell PLCex-dividend payment date
Spectris PLCex-dividend payment date
Supermarket Income REIT PLCdividend payment date
Target Healthcare REIT PLCex-dividend payment date
TClarke PLCex-dividend payment date
Tesco PLCex-dividend payment date
TwentyFour Select Monthly Income Fund Ltdex-dividend payment date
Unilever PLCex-dividend payment date
Vaalco Energy Incex-dividend payment date
Vector Capital PLCex-dividend payment date
Witan Investment Trust PLCex-dividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 14-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.